Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer-Reference-Cited by-同舟云学术

Ten-Year Results From a Phase II Study on Image Guided, Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in High-Risk Prostate Cancer

Published:2020-05 Issue:3 Volume:5 Page:396-403
ISSN:2452-1094
Container-title:Advances in Radiation Oncology
language:en
Short-container-title:Advances in Radiation Oncology

Author:

Ekanger Christian^ORCID,Helle Svein Inge,Heinrich Daniel,Johannessen Dag Clement,Karlsdóttir Ása,Nygård Yngve,Halvorsen Ole Johan,Reisæter Lars,Kvåle Rune,Hysing Liv Bolstad,Dahl Olav

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference38 articles.

1. Prostate cancer, version 1.2016;Mohler;J Natl Compr Canc Netw,2016

2. Dose-response in radiotherapy for localized prostate cancer: Results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy;Peeters;J Clin Oncol,2006

3. Long-term results of the MD. Anderson randomized dose-escalation trial for prostate cancer;Kuban;Int J Radiat Oncol Biol Phys,2008

4. Dose-escalated irradiation and overall survival in men with nonmetastatic prostate cancer;Kalbasi;JAMA Oncol,2015

5. Prostate alpha/beta revisited: An analysis of clinical results from 14 168 patients;Dasu;Acta Oncologica,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying dose perturbations in high‐risk prostate radiotherapy due to translational and rotational motion of prostate and pelvic lymph nodes;Medical Physics;2024-09-06

2. Tolérance à court et moyen terme d’une radiothérapie prostatique hypofractionnée selon la technique du boost intégré;Cancer/Radiothérapie;2024-08

3. Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up;Journal of Clinical Oncology;2024-06-01

4. Prospective results for 5-year survival and toxicity of moderately hypofractionated radiotherapy with simultaneous integrated boost (SIB) in (very) high-risk prostate cancer;Clinical and Translational Radiation Oncology;2024-01

5. Prostate Cancer;Geriatric Medicine;2024